ZA200205433B - Prostaglandin compositions and methods of treament for male erectile dysfunction. - Google Patents

Prostaglandin compositions and methods of treament for male erectile dysfunction.

Info

Publication number
ZA200205433B
ZA200205433B ZA200205433A ZA200205433A ZA200205433B ZA 200205433 B ZA200205433 B ZA 200205433B ZA 200205433 A ZA200205433 A ZA 200205433A ZA 200205433 A ZA200205433 A ZA 200205433A ZA 200205433 B ZA200205433 B ZA 200205433B
Authority
ZA
South Africa
Prior art keywords
composition
erectile dysfunction
prostaglandin
treament
methods
Prior art date
Application number
ZA200205433A
Other languages
English (en)
Inventor
James Yeager
Nadir Buyuktimkin
Servet Buyuktimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23909154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200205433(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of ZA200205433B publication Critical patent/ZA200205433B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
ZA200205433A 2000-01-10 2002-07-08 Prostaglandin compositions and methods of treament for male erectile dysfunction. ZA200205433B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/480,738 US6323241B1 (en) 2000-01-10 2000-01-10 Prostaglandin compositions and methods of treatment for male erectile dysfunction

Publications (1)

Publication Number Publication Date
ZA200205433B true ZA200205433B (en) 2003-11-26

Family

ID=23909154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205433A ZA200205433B (en) 2000-01-10 2002-07-08 Prostaglandin compositions and methods of treament for male erectile dysfunction.

Country Status (20)

Country Link
US (1) US6323241B1 (fr)
EP (1) EP1255552B1 (fr)
JP (2) JP2003519657A (fr)
KR (1) KR100614361B1 (fr)
CN (1) CN1394140A (fr)
AT (1) ATE290383T1 (fr)
AU (1) AU760576C (fr)
BE (1) BE2014C001I2 (fr)
BR (1) BR0107478A (fr)
CA (1) CA2395217C (fr)
DE (1) DE60109274T2 (fr)
ES (1) ES2236245T3 (fr)
HK (1) HK1047700B (fr)
HU (1) HUP0204159A3 (fr)
IL (2) IL150306A0 (fr)
MX (1) MXPA02006758A (fr)
PT (1) PT1255552E (fr)
TR (1) TR200201769T2 (fr)
WO (1) WO2001051053A1 (fr)
ZA (1) ZA200205433B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US6414028B1 (en) * 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US6825234B2 (en) * 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
EA008720B1 (ru) * 1998-12-10 2007-06-29 Нексмед (Холдингс), Инк. Применение композиции на основе простагландина для лечения расстройства сексуального возбуждения у женщин
US20050004226A1 (en) * 1998-12-10 2005-01-06 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6693135B2 (en) * 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) * 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US20040110843A1 (en) * 2000-01-10 2004-06-10 Nexmed (Holdings), Inc. Methods of treatment of male erectile dysfunction
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20090257956A1 (en) * 2002-01-25 2009-10-15 Ramsey Sallis Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation
PT1474143E (pt) 2002-01-25 2009-01-02 Modular Properties Ltd Métodos e composições para tratar a disfunção eréctil masculina
US20090035221A1 (en) * 2002-01-25 2009-02-05 Ramsey Sallis Methods and Compositions for Treatment of Erectile Dysfunction
IL162154A0 (en) * 2002-02-15 2005-11-20 Nexmed Holdings Inc Prostagandin composition for the treatment of erectile dysfunction
EA200500452A1 (ru) * 2002-09-06 2005-10-27 Нексмед (Холдингс), Инк. Способы лечения эректильной дисфункции у мужчин
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
KR101086147B1 (ko) 2003-03-21 2011-11-25 넥스메드 홀딩스 인코포레이티드 조루증 치료용 조성물 및 치료 방법
AU2004224413A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Prostaglandin compositions for the treatment of erectile dysfunction
CN1774237A (zh) * 2003-03-21 2006-05-17 尼克美制药控股有限公司 前列腺素组合物及其促进血管生成的方法
KR20050119187A (ko) * 2003-04-02 2005-12-20 넥스메드 홀딩스 인코포레이티드 프로스타글란딘 조성물 및 이의 혈관연축 치료용 용도
US20050159985A1 (en) * 2003-11-21 2005-07-21 Bertram Carl T. System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CN101005856A (zh) * 2004-08-19 2007-07-25 皮肤应用遗传学股份有限公司 吴茱萸果实提取物的仿生物用于缓解炎症
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
BR112013012799A8 (pt) * 2010-12-02 2018-01-09 Nexmed Holdings Inc formulário de dosagem, método de facilitação do transporte de um composto farmaceuticamente ativo através de uma membrana biológica ou tecido e composto farmaceuticamente ativo
RU2633236C2 (ru) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Способы и композиции для лечения болезни рейно
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
AU2016209490B2 (en) 2015-01-20 2020-09-03 Xoc Pharmaceuticals, Inc. Isoergoline compounds and uses thereof
WO2016118541A1 (fr) 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc Composés d'ergoline et leurs utilisations
EP3266458A1 (fr) 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile
CA3064274A1 (fr) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Derives d'ergoline destines a etre utilises en medecine

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2818855A (en) 1954-02-11 1958-01-07 Anthony P Miller Surgical device
BE790840A (fr) 1971-11-01 1973-04-30 Upjohn Co Solutions de medicaments instables et leur preparation
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4254145A (en) 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
US4311707A (en) 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
US4801587A (en) 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5256652A (en) 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5242391A (en) 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
KR0169950B1 (ko) 1990-04-25 1999-01-15 에드워드 엘. 멘델 발기 기능장애 치료용 제형, 어셈블리 및 조성물
US5380760A (en) 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
AU5358896A (en) 1995-03-14 1996-10-02 Vivus, Inc. Method and kit for preventing erectile dysfunction
KR20010021625A (ko) * 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
EP1027054A4 (fr) * 1997-10-28 2002-11-04 Vivus Inc Apport local d'inhibiteurs de phosphodiesterases, dans le traitement du dysfonctionnement erectile
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US5942545A (en) 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6102849A (en) 1999-04-03 2000-08-15 Hakac; John R. Non-surgical penile prosthesis

Also Published As

Publication number Publication date
ATE290383T1 (de) 2005-03-15
CN1394140A (zh) 2003-01-29
EP1255552A1 (fr) 2002-11-13
JP2007302690A (ja) 2007-11-22
BE2014C001I2 (fr) 2020-01-30
CA2395217C (fr) 2004-10-26
AU2934901A (en) 2001-07-24
MXPA02006758A (es) 2008-09-12
WO2001051053A1 (fr) 2001-07-19
DE60109274D1 (de) 2005-04-14
KR100614361B1 (ko) 2006-08-18
BR0107478A (pt) 2002-09-03
HK1047700B (zh) 2005-05-27
EP1255552B1 (fr) 2005-03-09
ES2236245T3 (es) 2005-07-16
HUP0204159A3 (en) 2005-03-29
KR20020073498A (ko) 2002-09-26
IL150306A0 (en) 2002-12-01
HUP0204159A2 (hu) 2003-04-28
AU760576B2 (en) 2003-05-15
CA2395217A1 (fr) 2001-07-19
AU760576C (en) 2004-04-08
IL150306A (en) 2007-06-03
US6323241B1 (en) 2001-11-27
PT1255552E (pt) 2005-06-30
HK1047700A1 (en) 2003-03-07
JP2003519657A (ja) 2003-06-24
TR200201769T2 (tr) 2002-11-21
DE60109274T2 (de) 2006-02-09

Similar Documents

Publication Publication Date Title
ZA200205433B (en) Prostaglandin compositions and methods of treament for male erectile dysfunction.
IL160404A0 (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction
ATE273714T1 (de) Topische zusammensetzungen zur prostaglandin e1 abgabe
TR200202308T2 (tr) Prostaglandin E1 içeren tropikal bileşimler
MXPA05009816A (es) Composiciones y metodos para el tratamiento de la eyaculacion precoz.
NO934355L (no) Proteinformulering omfattende veksthormon
HK1049789A1 (en) Solubilized pharmaceutical composition for parenteral administration
CA2442479A1 (fr) Compositions topiques d'apport de prostaglandine e1
TH8733A (th) ตัวปลุกฤทธิ์โปรตีนไคเนสเป็นตัวกระตุ้นการผลิตเมลานิน